Reportedly, during the initial three year term of the research collaboration, Halozyme is expected to receive exclusive worldwide commercial rights from BioAtla to conditionally active biologics (CABs), that
The company sold the assets of the business, which includes manufacturing facilities in Freehold and Irvington, New Jersey, to International Vitamin Corporation, and affiliates, for a total price
The agreement covers the distribution of Noveko antimicrobial masks and respirators, Microban hand sanitizers, air filters incorporating the Noveko antimicrobial filtration technology to hospitals and commercial buildings, as
As per the agreement, Immunomedics could potentially receive up to $580m from Nycomed upon achievement of certain clinical, regulatory, and sales-based milestones. The agreement also provides the company
The co-development and commercialisation agreement between Perseid and Astellas was originally entered into by Maxygen and Astellas in September 2008, and assigned to Perseid in September 2009, in
Access has focused its Cobalamin product development program on the oral delivery of insulin and human growth hormone. A new Cobalamin-coated insulin-containing nanoparticle formulation delivered orally, provided a
Reportedly, the randomised, double-blind, placebo-controlled, multi-centered study is expected to evaluate the safety, tolerability, and efficacy of Oramed’s oral insulin delivery technology. The company is conducting the study
Reportedly, the verbal Memorandum of Understanding (MOU) will give Wellfield an option for distributing the products in Guangdong and throughout the southern region of China. Evaluations and due
The notice is a routine end-of-review communication from Health Canada when additional information is needed to reach final decision on product approval. NexMed has 90 days from the
The US Nuclear Regulatory Commission has approved a license amendment permitting the use of GEH’s technology at Exelon Nuclear’s Clinton Power Station, a single-unit, boiling water reactor plant
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.